Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Sell
35
CLPT Quote, Financials, Valuation and Earnings
Last price:
$14.08
Seasonality move
:
14.02%
Day range:
$13.60 - $14.19
52-week range:
$9.76 - $30.10
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
11.47x
P/B ratio:
25.18x
Volume:
478.9K
Avg. volume:
861K
1-year change:
10.53%
Market cap:
$399.6M
Revenue:
$31.4M
EPS (TTM):
-$0.83
Analysts' Opinion
-
Consensus RatingClearpoint Neuro, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $29.00, Clearpoint Neuro, Inc. has an estimated upside of 106.26% from its current price of $14.06.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $28.00 representing 100% downside risk from its current price of $14.06.
Fair Value
-
According to the consensus of 2 analysts, Clearpoint Neuro, Inc. has 106.26% upside to fair value with a price target of $29.00 per share.
CLPT vs. S&P 500
-
Over the past 5 trading days, Clearpoint Neuro, Inc. has underperformed the S&P 500 by -2.75% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Clearpoint Neuro, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Clearpoint Neuro, Inc. has grown year-over-year revenues for 21 quarters straight. In the most recent quarter Clearpoint Neuro, Inc. reported revenues of $8.9M.
Earnings Growth
-
Clearpoint Neuro, Inc. earnings have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter Clearpoint Neuro, Inc. reported earnings per share of -$0.21.
Enterprise value:
397.2M
EV / Invested capital:
7.69x
Price / LTM sales:
11.47x
EV / EBIT:
--
EV / Revenue:
11.57x
PEG ratio (5yr expected):
-0.87x
EV / Free cash flow:
-28.73x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$21.1M
Return On Assets:
-49.73%
Net Income Margin (TTM):
-67.4%
Return On Equity:
-105.19%
Return On Invested Capital:
-60.29%
Operating Margin:
-59.54%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $22.3M | $30.4M | $34.3M | $8.1M | $8.9M | |
| Gross Profit | $12.9M | $18.4M | $21.1M | $4.8M | $5.6M | |
| Operating Income | -$22.2M | -$18.8M | -$22.7M | -$5.2M | -$5.3M | |
| EBITDA | -$21M | -$16.9M | -$20.9M | -$4.7M | -$4.9M | |
| Diluted EPS | -$0.89 | -$0.69 | -$0.83 | -$0.18 | -$0.21 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $65M | $53.8M | $37.3M | $34.3M | $51.3M | |
| Total Assets | $68.7M | $57.7M | $43.8M | $40.2M | $60.4M | |
| Current Liabilities | $4.6M | $6.1M | $5.6M | $7.6M | $8.1M | |
| Total Liabilities | $24.6M | $17.9M | $19.7M | $11.2M | $44.5M | |
| Total Equity | $44.1M | $39.9M | $24.1M | $29M | $15.9M | |
| Total Debt | $19.7M | $11.4M | $13.6M | $3.2M | $35.4M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$15.6M | -$8.9M | -$13.1M | -$1.2M | -$3.1M | |
| Cash From Investing | $20.9M | -$200K | -$736K | -$12K | -$199K | |
| Cash From Financing | $363K | $6.3M | $30.7M | -$10.1M | -- | |
| Free Cash Flow | -$16.7M | -$9.1M | -$13.8M | -$1.2M | -$3.3M | |
CLPT
Sector
Market Cap
$399.6M
$28.4M
Price % of 52-Week High
46.71%
50.35%
Dividend Yield
0%
0%
Shareholder Yield
-1.31%
-1.32%
1-Year Price Total Return
10.54%
-22.19%
Beta (5-Year)
1.008
0.521
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$14.14
200-day SMA
Sell
Level
$14.31
Bollinger Bands (100)
Sell
Level
9.72 - 21.84
Chaikin Money Flow
Buy
Level
11.9M
20-day SMA
Sell
Level
$14.93
Relative Strength Index (RSI14)
Sell
Level
37.51
ADX Line
Sell
Level
31.94
Williams %R
Neutral
Level
-64.6667
50-day SMA
Sell
Level
$20.51
MACD (12, 26)
Sell
Level
-1.68
25-day Aroon Oscillator
Sell
Level
-92
On Balance Volume
Sell
Level
-4.4M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (11.4739)
Sell
CA Score
(Annual)
Level (-2.0229)
Buy
Beneish M-Score
(Annual)
Level (-3.4783)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (3.7119)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Clearpoint Neuro, Inc. engages in the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain and heart. The firm conducts its procedures under direct, intra-procedural magnetic resonance imaging guidance. Its product platform consists of the ClearPoint system and ClearTrace system. The company was founded by Paul A. Bottomley on March 12, 1998 and is headquartered in Solana Beach, CA.
Stock Forecast FAQ
In the current month, CLPT has received 2 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CLPT average analyst price target in the past 3 months is $29.00.
-
Where Will Clearpoint Neuro, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Clearpoint Neuro, Inc. share price will rise to $29.00 per share over the next 12 months.
-
What Do Analysts Say About Clearpoint Neuro, Inc.?
Analysts are divided on their view about Clearpoint Neuro, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Clearpoint Neuro, Inc. is a Sell and believe this share price will drop from its current level to $28.00.
-
What Is Clearpoint Neuro, Inc.'s Price Target?
The price target for Clearpoint Neuro, Inc. over the next 1-year time period is forecast to be $29.00 according to 2 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is CLPT A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Clearpoint Neuro, Inc. is a Buy. 2 of 2 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of CLPT?
You can purchase shares of Clearpoint Neuro, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Clearpoint Neuro, Inc. shares.
-
What Is The Clearpoint Neuro, Inc. Share Price Today?
Clearpoint Neuro, Inc. was last trading at $14.08 per share. This represents the most recent stock quote for Clearpoint Neuro, Inc.. Yesterday, Clearpoint Neuro, Inc. closed at $14.06 per share.
-
How To Buy Clearpoint Neuro, Inc. Stock Online?
In order to purchase Clearpoint Neuro, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get CLPT Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CLPT
Sector
P/E ratio
--
23.66x
PEG ratio
-0.87x
-0.01x
P/B ratio
25.18x
1.84x
Price / LTM sales
11.47x
1.60x
Growth Metrics
CLPT
Sector
Revenue growth
9.1%
4.85%
Earnings growth
-14.92%
11.15%
Revenue (5-year growth)
22.85%
6.45%
Earnings forecast
-$0.20
-$0.20
Profitability
CLPT
Sector
Profitability FY 2024
$19.1M
$3.6M
Return on invested capital
-60.29%
-30.98%
Return on assets
-49.73%
-27.62%
Return on equity
-105.19%
-36.69%
Earnings Date
Last Earnings Date
Nov
6
Next Earnings Date
Feb
25
Estimated Next Earnings Date
Feb
5
Balance Sheet
CLPT
Sector
Total cash
$38.2M
$27.2M
Short term investments
--
$25.7M
Total assets
$39.2M
$79.9M
Long term debt
$35.4M
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Sell
50
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 61x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 38x
Buy
63
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 40x
Alerts
Sell
39
PSTG alert for Dec 5
Pure Storage, Inc. [PSTG] is up 5.05% over the past day.
Sell
38
HOV alert for Dec 5
Hovnanian Enterprises, Inc. [HOV] is down 22.58% over the past day.
Buy
69
ASTS alert for Dec 5
AST Spacemobile, Inc. [ASTS] is up 18.25% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
